| 000 | 01420 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516013801.0 | ||
| 264 | 0 | _c20110314 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1535-2900 | ||
| 024 | 7 |
_a10.2146/ajhp100020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorders, Emily B | |
| 245 | 0 | 0 |
_aMammalian target of rapamycin: biological function and target for novel anticancer agents. _h[electronic resource] |
| 260 |
_bAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists _cDec 2010 |
||
| 300 |
_a2095-106 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSirolimus _xadverse effects |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aBivona, Cory | |
| 700 | 1 | _aMedina, Patrick J | |
| 773 | 0 |
_tAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists _gvol. 67 _gno. 24 _gp. 2095-106 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2146/ajhp100020 _zAvailable from publisher's website |
| 999 |
_c20408530 _d20408530 |
||